本页面由Tiger Trade Technology Pte. Ltd.提供服务

ICU医疗

163.91
+3.592.24%
盘后:163.910.00000.00%19:30 EDT
成交量:20.14万
成交额:3,284.32万
市值:40.97亿
市盈率:136.17
高:164.40
开:159.73
低:159.50
收:160.32
52周最高:192.85
52周最低:112.50
股本:2,499.24万
流通股本:2,451.32万
量比:0.98
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):1.20
每股收益(LYR):0.0297
净资产收益率:1.41%
总资产收益率:1.93%
市净率:1.90
市盈率(LYR):5,517.55

数据加载中...

2026/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors